Literature DB >> 19605332

Isolated pancreatic metastasis of a malignant pleural mesothelioma.

Yi-Ting Lin1, Bing-Shiun Wu, Sheau-Fang Yang, Huang-Chi Chen.   

Abstract

Metastatic malignant mesothelioma of the pleura is uncommon at the time of initial diagnosis. When metastases are present, the major sites always include regional lymph nodes, the contralateral lung, liver, adrenal glands and kidneys. Here, we describe an extremely rare case of isolated pancreatic metastasis of mesothelioma of the pleura in a 40-year-old man who initially presented with epigastric discomfort and hunger pain, which were refractory to medical treatments. The possibility of pancreatic metastatic lesion should be considered in patients with malignant pleural mesothelioma in the presence of refractory epigastric tenderness.

Entities:  

Mesh:

Year:  2009        PMID: 19605332     DOI: 10.1016/S1607-551X(09)70533-9

Source DB:  PubMed          Journal:  Kaohsiung J Med Sci        ISSN: 1607-551X            Impact factor:   2.744


  5 in total

Review 1.  Intra-abdominal manifestations of pleural mesothelioma.

Authors:  Paul H Sugarbaker
Journal:  Ann Transl Med       Date:  2017-06

2.  Malignant pleural mesothelioma presenting as rectal polyp: a case report and review of the literature.

Authors:  Bassam Alhaddad; Natali Alkhouri Saad; Hamed A Daw; Sebouh Setrakian; Abdo Haddad
Journal:  Gastrointest Cancer Res       Date:  2012-09

3.  A Rare Case of Malignant Pleural Mesothelioma with Metastases to the Pancreas Concurrently Diagnosed with Invasive Ductal Adenocarcinoma.

Authors:  Chelsea Wuthnow; Yasmine Hussein Agha; Sachin Srinivasan; William Salyers; Nathan Tofteland
Journal:  Kans J Med       Date:  2020-10-20

Review 4.  Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer.

Authors:  Takeshi Okamoto
Journal:  World J Gastroenterol       Date:  2022-03-14       Impact factor: 5.742

Review 5.  When the Diagnosis of Mesothelioma Challenges Textbooks and Guidelines.

Authors:  Giulio Rossi; Fabio Davoli; Venerino Poletti; Alberto Cavazza; Filippo Lococo
Journal:  J Clin Med       Date:  2021-05-30       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.